The Global Breast Imaging Market, by Technology (Ionizing Breast Imaging Technology (Analog Mammography, Full Field Digital Mammography (FFDM), 3D Breast Tomosynthesis, Positron Emission Tomography/ Computed Tomography (PET/CT), Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI), Positron Emission Mammography, Others), Non-Ionizing Breast Imaging Technology (Breast MRI (Magnetic Resonance Imaging), Breast Ultrasound, Optical Imaging, Automated Whole Breast Ultrasound (AWBU), Breast Thermography)), by End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers) was valued at US$ 3,150.3 million in 2017, and is projected to exhibit a CAGR of 9.9% over the forecast period (2018 - 2026). Breast imaging techniques plays a major role in early diagnosis of the breast disease by providing detailed representation of breast form with high resolution, evaluating the progress of the disease and further helps in deciding the best possible treatment. One of factors driving growth of the breast imaging market is increasing awareness among population regarding breast cancer. The American Cancer Society, Inc. advises men and women to attend self-awareness exams conducted through the year, which helps individual to detect any change in their breast, which would be further diagnosed by the physician. High incidence of breast cancer is also fueling growth of the breast imaging market. According to the National Cancer Institute (NCI), 2015, in the U.S. around 232,340 females were reported to be suffering from breast cancer, out of which 39,620 cases were lethal. Furthermore, the American Cancer Society (ACS) states that 1 out of 4 patients diagnosed with cancer are victims of breast cancer and it is the most commonly observed cancer in females.

Browse 23 Market Data Tables and 26 Figures spread through 155 Pages and in-depth TOC on "Breast Imaging Market, by Technology (Ionizing Breast Imaging Technology (Analog Mammography, Full Field Digital Mammography (FFDM), 3D Breast Tomosynthesis, Positron Emission Tomography/ Computed Tomography (PET/CT), Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI), Positron Emission Mammography, Others), Non-Ionizing Breast Imaging Technology (Breast MRI (Magnetic Resonance Imaging), Breast Ultrasound, Optical Imaging, Automated Whole Breast Ultrasound (AWBU), Breast Thermography)), by End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers) - Global Forecast to 2026"

To know the latest trends and insights related to breast imaging market, click the link below:

https://www.coherentmarketinsights.com/market-insight/breast-imaging-market-2040

Manufactures in breast imaging market are focused on receiving Food and Drug Administration (FDA) approval for technologically advanced products to be commercialized in the market. For instance, in April 2017, Siemens Healthineers received the US FDA approval for their High Definition Breast Tomosynthesis, which integrates Enhanced Multiple Parameter Iterative Reconstruction (EMPIRE) technology to deliver a high level of sensitivity for breast cancer detection and diagnosis over 2-D mammography alone. Furthermore, in 2017, GE Healthcare received the US FDA clearance for Senographe Pristina Dueta, a remote control patient-assisted mammography device allows women to manage their own compression during the exam performed on this system, thus helping in reducing the pain associated with imaging.

Key Takeaways of the Breast Imaging Market:

  • The global breast imaging market is expected to expand at a CAGR of 9.9% during the forecast period (2018 – 2026), owing to continuous technological advancement and increasing incidence of breast cancers in various regions of world
  • Among technology, ionizing Breast Imaging Technology segment holds the major market share as this technology provides images of breast with high diagnostic accuracy and enhanced efficiency as compared to other available technologies, which is expected to aid market growth.
  • Major players operating in the global breast imaging market include Hologic, Inc., General Electric Company, Siemens AG, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us: